37517-28-5Amikacin Working Standard (Secondary Reference Standard)
● Under Development
| Katalog-Nr.:: | VE0027222 |
|---|---|
| CAS-Nr.:: | 37517-28-5 |
| Summenformel:: | C22H43N5O13 |
| Molare Masse:: | 585.60 g/mol |
Zusätzliche Informationen zu CAS 37517-28-5
Parent drug
AmikacinIUPAC-Name
6-O-(3-Amino-3-deoxy-α-D-glucopyranosyl-4-O-[6-amino-6-deoxy-α-D-glucopyranosyl-1-N-(2S) (4-amino-2-hydroxybutanoyl)-2-deoxy-D-streptamine)SMILES
O[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](NC([C@@]([H])(O)CCN)=O)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)O[C@H](CN)[C@H]1OInChI
InChI=1S/C22H43N5O13/c23-2-1-8(29)20(36)27-7-3-6(25)18(39-22-16(34)15(33)13(31)9(4-24)37-22)17(35)19(7)40-21-14(32)11(26)12(30)10(5-28)38-21/h6-19,21-22,28-35H,1-5,23-26H2,(H,27,36)/t6-,7+,8-,9+,10+,11-,12+,13+,14+,15-,16+,17-,18+,19-,21+,22+/m0/s1Beschreibung
Amikacin Working Standard (Secondary Reference Standard), CAS 37517-28-5, is a batch-traceable calibration material supplied with a lot-specific Certificate of Analysis and an assigned potency value determined by validated analytical methods. It is intended solely for research and analytical method development and is not certified for use as a primary reference standard for GMP QC batch release or regulatory stability studies. Supplied with documented storage and handling conditions to preserve integrity, the material is characterized for identity, assay and impurity profile using orthogonal techniques to support reproducible method performance. Users should follow laboratory quality systems for in-house verification and stability tracking.Angebot anfordern
„*“ zeigt erforderliche Felder an









